Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames V.2 Dp67 Regulatory News (D467)

Share Price Information for Thames V.2 Dp67 (D467)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 9.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 10.00 (111.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.00
D467 Live PriceLast checked at -
Downing FOUR VCT DP67 shares is an Investment Trust

To provide Shareholders with an attractive level of tax-free capital gains and income generated from a portfolio of investments in a range of different sectors.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and Board Changes

8 Sep 2021 17:17

Result of AGM and Board Changes

Downing FOUR VCT plc LEI: 21380035MV1VRYEXPR95 Result of AGM and Board Changes8 September 2021

Result of AGM

At the Annual General Meeting of Downing FOUR VCT plc, held at 11.00 a.m. on 8 September 2021, all resolutions were passed.

Details of the proxy votes in respect of the resolutions passed at the Annual General Meeting received as at 11:00 a.m. on 6 September 2021, 48 hours before the time of the meeting (excluding weekends), at Downing LLP are set out below:

 ForDiscretionaryAgainst Withheld
Resolution No.No. ofNo. ofNo. ofTotalNo. of
VotesVotesVotesVotes CastVotes
% of votes% of votes% of votes% of votes 
11,770,804,315 50,396,4965,171,1801,826,371,99122,500,000
96.96%2.76%0.28%100.00% 
21,644,796,105 55,036,496123,729,8901,823,562,49125,309,500
90.20%3.02%6.78%100.00% 
31,741,449,317 50,396,49647,923,4281,839,769,2419,102,750
94.66%2.74%2.60%100.00% 
41,735,869,090 55,036,49616,350,1251,807,255,71141,616,280
96.05%3.05%0.90%100.00% 
51,631,234,680 55,036,496150,846,2651,837,117,44111,754,550
88.79%3.00%8.21%100.00% 
61,676,808,307 50,396,49657,027,1881,784,231,99164,640,000
93.98%2.83%3.19%100.00% 

A copy of the resolutions passed will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Board ChangesAt the meeting, the Chairman, Sir Aubrey Brocklebank, made the following announcement:

“As noted in my statement in the Annual Report, the Company has undertaken a review of the composition of the Board and undertaken a formal process, with an external recruitment consultant, to identify suitable board candidates.

I am pleased to report that this process is now complete and has produced two new non-executive directors, Dr Andrew Mackintosh and Steven Clarke, who will join the Board with immediate effect.

A brief background on each is as follows:

Dr Andrew Mackintosh has had a distinguished career in industry and investment as a former CEO of FTSE 250 company, Oxford Instruments, before later leading the creation of the Royal Society Enterprise Fund, a pioneering initiative in bringing together scientific expertise and early-stage investment. He was a Board Member of the Intellectual Property Office and a trustee of the Design Council and is currently chairman of Sphere Fluidics Limited, a high-growth biotechnology tools company. He has recently become chairman of UKI2S, a government-backed venture capital fund supporting companies from the UK’s scientific research base.

He has a longstanding interest in enhancing the commercialisation and wider economic impact of UK research. Since 2015 he has been a non-executive director of Ploughshare Innovations Limited, the technology transfer organisation for the UK Ministry of Defence. In 2019 he led a Treasury project which resulted in the publication in April this year of ‘The Mackintosh Report: Getting smarter: a strategy for knowledge & innovation assets in the public sector’ and the launch of an initiative with £17m of government funding to support commercialisation of publicly owned technologies and ideas. Dr Mackintosh has a PhD in physics from the University of Cambridge, is a Fellow of the Institute of Physics and of Hughes Hall, Cambridge and a trustee of City, University of London.

Steven Clarke has 30 years’ experience of investing in technology and data businesses including 21 years as a private equity investor with 3i, August Equity and ICG. Steven now supports founders through fundraising, international growth and exit as an investing non-executive director usually alongside a growth equity fund. Steven is also Chair of investment Committee for Bethnal Green Ventures, a Tech for Good impact investor.

In addition, Chris Allner, a partner of Downing LLP ("Downing"), the investment manager, and chair of Downing's Investment Committee, will also join the Board as a further non-executive director. The Board believes that Chris’ appointment will be beneficial to the relationship between the Board and the Investment Manager. Chris undertakes a similar role on Downing ONE VCT plc, which has worked well. Chris will not be remunerated as a director of Downing FOUR VCT plc.

A final change is that Russell Catley has stepped down as a non-executive director of the Company with immediate effect. Russell joined the Company’s board following the merger with three other VCTs in 2015. Russell has made excellent contributions throughout his period on the board, particularly in respect of the structured product portfolios which were part of the investment strategy of some of the Company’s historic share pools. I and my colleagues will miss working with Russell and wish him all the very best in his future activities.

I believe that these changes result in a board which has an excellent balance of skills and experience to oversee the type of investment activity on which the Company in now focussed. I very much look forward to working with the new directors and the fresh insight that I am certain they will bring.”

Date   Source Headline
28th Mar 20241:15 pmGNWCancellation of Listing of DSO D Shares and Cessation of Trading
15th Mar 202410:21 amGNWNet Asset Value(s)
29th Feb 20244:58 pmGNWDividend Declaration
21st Dec 20233:34 pmGNWHalf Yearly Results
18th Oct 20234:33 pmGNWSpecial administration of the Company’s custodian of quoted assets
13th Sep 20235:14 pmGNWNet Asset Values
13th Sep 20235:06 pmGNWCompany Secretary Change
13th Sep 20235:03 pmGNWResult of AGM
31st Jul 20233:57 pmGNWClosure of Offers for Subscription
31st Jul 20233:14 pmGNWFinal Results
31st May 20235:28 pmGNWTotal Voting Rights
30th May 20232:12 pmGNWOffer for Subscription Extension
12th May 20231:42 pmGNWIssue of Equity
2nd May 202310:49 amGNWTotal Voting Rights
5th Apr 20236:24 pmGNWIssue of Equity
31st Mar 20236:04 pmGNWTotal Voting Rights
31st Mar 20235:44 pmGNWTransaction in Own Shares
22nd Mar 20234:14 pmGNWNet Asset Values
31st Jan 20235:45 pmGNWTotal Voting Rights
17th Jan 20234:57 pmGNWTransaction in Own Shares & Total Voting Rights
22nd Dec 20225:08 pmGNWHalf-year report
13th Oct 20225:35 pmGNWPublication of Healthcare Prospectus
12th Oct 20224:40 pmGNWPortfolio Update and Net Asset Values
30th Sep 20225:27 pmGNWTotal Voting Rights
30th Sep 20225:25 pmGNWTransaction in Own Shares
28th Sep 20223:19 pmGNWDirectorate change
27th Sep 20225:56 pmGNWResult of AGM
7th Sep 202212:00 pmGNWChange of Name
1st Sep 202210:05 amGNWTotal Voting Rights
31st Aug 20224:59 pmGNWShare forfeiture and cancellation
3rd Aug 20225:12 pmGNWTransaction in Own Shares and Total Voting Rights
26th Jul 20227:00 amGNWNet Asset Value(s)
25th Jul 20226:28 pmGNWFinal Results
5th Jul 20227:00 amGNWCompletion of Sale of Downing non-healthcare ventures business to Foresight Group and Novation of Investment Management Agreement
30th Jun 20226:30 pmGNWTotal Voting Rights
13th Jun 20227:04 amGNWNovation of Investment Management Agreement
6th Jun 20224:34 pmGNWIssue of Equity
3rd May 202210:38 amGNWTotal Voting Rights
19th Apr 202211:29 amGNWIssue of Equity
6th Apr 202210:46 amGNWIssue of Equity
31st Mar 20225:46 pmGNWTotal Voting Rights
31st Mar 20225:35 pmGNWTransaction in Own Shares
30th Mar 20226:24 pmGNWIssue of Equity
4th Mar 20225:20 pmGNWTransaction in Own Shares
1st Mar 20225:35 pmGNWIssue of Equity
1st Mar 20229:09 amGNWTotal Voting Rights
28th Feb 202212:55 pmGNWNet Asset Value(s)
2nd Feb 20228:10 amGNWIssue of Equity
31st Jan 20225:09 pmGNWTotal Voting Rights
7th Jan 20222:54 pmGNWIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.